Abstract Library

#2273 The Clinical Value of Circulating Transcript Analysis (NETest) during Follow-Up of Resected Well-Differentiated Pancreatic Neuroendocrine Tumors

Introduction: Follow-up after resection of pancreatic neuroendocrine tumors (pNET) is designed to detect recurrence early, as incidence is reported up to 48%.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Genc C, Jilesen A, Nieveen van Dijkum E, Klümpen H, Van Eijck C,

Keywords: neuroendocrine, pancreas, recurrence, biomarker, NETest, postoperative follow-up,

#1714 CALM-NET, A Multicentre, Exploratory Study to Assess the Clinical Value of Circulating Tumour Cells (CTCs) Enumeration in Patients (Pts) with Functioning Midgut NETs Receiving Lanreotide Autogel (LAN)

Introduction: The presence of CTCs confers adverse prognosis in metastatic NET pts with heterogenous treatment history. Post treatment CTC count correlates with disease progression and overall survival.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Meyer T

Authors: Meyer T, Higgs K, Hickling M, Houchard A,

Keywords: midgut neuroendocrine tumor, CTC, lanreotide,

#1599 The Value of Plasma CgA Combined with NSE Performed As the Real-Time Monitor of Clinical Characteristics in Gastroenteropancreatic Neuroendocrine Neoplasms after the Resection of Primary Lesions

Introduction: Controversies still remain on the clinical value of CgA and NSE.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Lv Y, Han X, Mao W, Zhou J, Li J,

Keywords: cga, nse, nf-gep-nens,

#1598 The Exploration of the Clinical Value of Plasma CgA in Nonfunctional Gastroenteropancreatic Neuroendocrine Neoplasms

Introduction: Controversies still remain on the clinical value of CgA.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Lv Y, Han X, Mao W, Zhou J, Li J,

Keywords: cgA, NF-GEP-NENs, clinical value,

#1299 Clinical Value of Somatostatin Receptor Scintigraphy in the Management of Medullary Thyroid Carcinoma

Introduction: Medullary Thyroid Carcinoma (MTC) is a rare form of thyroid cancer. It represents 5 to 10 % of these cancers. MTC grows from specialized thyroid cells called para-follicular cells, or C-cells that secrete a hormone called calcitonin. Its prognosis is usually good. Recurrences can occur, requiring lifelong surveillance.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Khamla E

Authors: Khamla E, Ben Sellem D, Ben Slimene M,

Keywords: Medullary Thyroid Carcinoma, Somatostatin Receptor Scintigraphy, Management ,